te Boekhorst Paul Francis Olivier
Reporting owner on Forms 3, 4 and 5, CIK 2095704.
te Boekhorst Paul Francis Olivier reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-11-16.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| ICCC · IMMUCELL CORP /DE/CIK 811641 | director, officer (President and CEO) | 1 | 2026-11-16 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| ICCC · IMMUCELL CORP /DE/Common Stock, par value $.10 per share | 2026-11-12 | M exercised | +16,393 | $6.1 | 34,131 | Form 4 |
| ICCC · IMMUCELL CORP /DE/Incentive Stock Options (Right to buy), derivative | 2026-11-12 | M exercised | -16,393 | $0 | 57,884 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001437749-26-037085 | IMMUCELL CORP /DE/ | 2026-11-16 |